Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist

China Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist, Find details about China Medical Supply, Medical Products from Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist

Min. Order: 1 Piece
Port: Shenzhen, China
Transport Package: Box+Carton
Payment Terms: L/C, T/T, Western Union
Certification: CE, ISO13485
Origin: China
Fluorescence immunochromatography intelligent detection system for serum gastric function
Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist
To solve gastric function in the process of testing operation trival, inconvenient operation, Medomics research and development team joint machine by the Chinese Academy of Sciences and other scientific research institutes, after two years of efforts, introduced a set of touch screen, printing, the lis interface, quality control, intelligent interpretation of thousand of fluorescent immune chromatography smartphone Tricell card detection reagent and stomach function, has realized the rapid clinical diagnosis, improve the efficiency of turnover,Comprehensive cost saving, with a good market prospect.
Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist


Technical characteristics of HIT-92A instrument
The instrument adopts advanced technologies such as coaxial illumination imaging, multiple stray light suppression, self-calibration and stable light source, and selects high-performance imported detectors and 24-bit high-precision AD, which can achieve extremely high detection sensitivity and inspection accuracy.
Performance attainable
· Sensitivity: 1000 ESE high detection limit
· Testability: Linear is comparable to ESE, the industry benchmark
· Reliability of single test: Repeatability is better than ESE
· Reliability of long-term detection: better stability than ESE
Instrument/IndexLimit of detectionLinearRepeatabilityStability
HIT-92A0.8µg/ml0.99820.04%0.02%
ESE3.125µg/ml0.99710.66%0.80%


Reagent basic parameters
The detection sensitivity reached pg level
 Detection range Sample typeSample capacityDetection limitReaction timeSpecificationsStorage conditions
Gastrin17 1.0-47.8
pmol/L
Serum80µL0.5pmol/L15min25tests/kit2°C-30°C
Pepsin I1.9-210
µg/L
Serum80µL1.9µg/L15min25tests/kit2°C-30°C
Pepsinogen II1.0-60
µg/L
Serum80µL1.0µg/L15min25tests/kit2°C-30°C


Simple operation process
Step1:Add 80µl to the sample
Step2:React for 15 minutes
Step3:Insert reagent strip
Step4:Click"Measure"
Step5:Automatic printing of measurement results


 
Instruction for gastric function test
Serum gastric function test is a method by extracting 2 ~ 3ml of human venous blood (fasting) and determining the content of gastrin 17 (G-17).Pepsinogen I, II (PG I, II), combined with comprehensive analysis to assist in the diagnosis of gastric mucosal diseases, whose core index is G-17, is a non-invasive, painless, safe and economic gastric disease detection method.
Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist
Significance of each test index:

1.PGI<30ug/L , moderate or severe atrophic gastritis in the stomach

2.PGII>11ug/L, stomach inflammation

3.PGR<=3, Severe atrophic gastritis

4.G-17 <=1pmol/L, high acid
G-17≥7pmol/L, low acid (low acid is a high-risk environment for gastric cancer, most of which is caused by atrophic gastritis)

5.Those who are positive for Hp antibodies with PGII > 11ug/L indicates Hp present infection

 

About Medomics
Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.  

Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.



Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist
Contact Medomics
Medomics Serum Gastric Function Fluorescence Detection System with CE/Whitelist